CSF2 and neoplasm: In a preclinical study, local injection of GM-CSF, IL-2, and HPV16 E7 peptide enhanced vaccine-specific immune responses and induced higher CTL and cytokine release without increasing immunosuppressive Treg cells, more effectively inhibiting the growth of TC-1 tumor cells [274].